US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Pasithea Therapeutics Corp Warrant

0.0120

0.0000

Volume:- -

Turnover:- -

Market Cap:89.32K

PE:0.00

High:0.0120

Open:0.0120

Low:0.0120

Close:0.0120

52wk High:0.1198

52wk Low:0.0100

Shares:7.44M

Float Shares:7.44M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-5.2115

ROE:-8.41%

ROA:-10.52%

PB:0.00

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Pasithea Therapeutics Corp Warrant

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

- -

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Pasithea Therapeutics Corp., a biotechnology company, engages in discovery, research, and development of treatments for central nervous system disorders, RASopathies, and other diseases. Its lead product candidate PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor for use in the treatment of a range of RASopathies, including neurofibromatosis type 1 oncology indications. The company intends to develop PAS-003, to treat amyotrophic lateral sclerosis; and PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/KTTAW/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KTTAW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KTTAW\",,,,,undefined,":{"symbol":"KTTAW","market":"US","secType":"STK","nameCN":"Pasithea Therapeutics Corp Warrant","latestPrice":0.012,"timestamp":1771621200000,"preClose":0.012,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":7443563,"shares":7443563,"eps":-5.2115,"marketStatus":"Market Closed","change":0,"latestTime":"02-20 16:00:00 EST","open":0.012,"high":0.012,"low":0.012,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.2115,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"listingDate":1631678400000,"exchange":"NASDAQ","adjPreClose":0.012,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KTTAW\",,,,,undefined,":{"symbol":"KTTAW","floatShares":7443563,"roa":"-10.52%","roe":"-8.41%","lyrEps":0,"shares":7443563,"dividePrice":0,"high":0.012,"amplitude":0,"preClose":0.012,"low":0.012,"week52Low":0.01,"pbRate":"0.00","psRate":"2.11","week52High":0.1198,"institutionHeld":0,"latestPrice":0.012,"eps":-5.2115,"divideRate":0,"volume":0,"delay":0,"ttmEps":-5.2115,"open":0.012,"prevYearClose":0.0141,"prevWeekClose":0.0137,"prevMonthClose":0.0142,"prevQuarterClose":0.0141,"fiveDayClose":0.0137,"twentyDayClose":0.0145,"sixtyDayClose":0.0123},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KTTAW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KTTAW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KTTAW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"stockEarnings":[{"period":"1week","weight":-0.1241},{"period":"1month","weight":-0.1724},{"period":"3month","weight":-0.0244},{"period":"6month","weight":-0.397},{"period":"1year","weight":-0.4146},{"period":"ytd","weight":-0.1489}],"compareEarnings":[{"period":"1week","weight":0.0113},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0461},{"period":"6month","weight":0.0684},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.011}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Pasithea Therapeutics Corp., a biotechnology company, engages in discovery, research, and development of treatments for central nervous system disorders, RASopathies, and other diseases. Its lead product candidate PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor for use in the treatment of a range of RASopathies, including neurofibromatosis type 1 oncology indications. The company intends to develop PAS-003, to treat amyotrophic lateral sclerosis; and PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.047226},{"month":2,"riseRate":0,"avgChangeRate":-0.261078},{"month":3,"riseRate":0.75,"avgChangeRate":0.126582},{"month":4,"riseRate":0.5,"avgChangeRate":0.012739},{"month":5,"riseRate":0.5,"avgChangeRate":-0.039385},{"month":6,"riseRate":0.25,"avgChangeRate":-0.152142},{"month":7,"riseRate":0.25,"avgChangeRate":0.597648},{"month":8,"riseRate":0.25,"avgChangeRate":-0.176901},{"month":9,"riseRate":0.5,"avgChangeRate":0.550542},{"month":10,"riseRate":0.2,"avgChangeRate":-0.294041},{"month":11,"riseRate":0.4,"avgChangeRate":1.069252},{"month":12,"riseRate":0.2,"avgChangeRate":-0.148272}],"exchange":"NASDAQ","name":"Pasithea Therapeutics Corp Warrant","nameEN":"Pasithea Therapeutics Corp Warrant"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"KTTAW\",market:\"US\",,,undefined,":null}}